Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
Taylor D, Meyer CT, Graves D, Sen R, Fu J, Tran E, Mirza B, Rodriguez G, Lang C, Feng H, Quaranta V, Wilson JT, Kim YJ, Korrer MJ. Taylor D, et al. Among authors: wilson jt. Front Immunol. 2022 Aug 19;13:936129. doi: 10.3389/fimmu.2022.936129. eCollection 2022. Front Immunol. 2022. PMID: 36059502 Free PMC article.
At the bench: Engineering the next generation of cancer vaccines.
Shae D, Baljon JJ, Wehbe M, Becker KW, Sheehy TL, Wilson JT. Shae D, et al. Among authors: wilson jt. J Leukoc Biol. 2020 Oct;108(4):1435-1453. doi: 10.1002/JLB.5BT0119-016R. Epub 2019 Aug 20. J Leukoc Biol. 2020. PMID: 31430398 Review.
Pharmacological Activation of cGAS for Cancer Immunotherapy.
Garland KM, Rosch JC, Carson CS, Wang-Bishop L, Hanna A, Sevimli S, Van Kaer C, Balko JM, Ascano M, Wilson JT. Garland KM, et al. Among authors: wilson jt. Front Immunol. 2021 Nov 26;12:753472. doi: 10.3389/fimmu.2021.753472. eCollection 2021. Front Immunol. 2021. PMID: 34899704 Free PMC article.
Dual-Responsive Glycopolymers for Intracellular Codelivery of Antigen and Lipophilic Adjuvants.
De Mel J, Hossain M, Shofolawe-Bakare O, Mohammad SA, Rasmussen E, Milloy K, Shields M, Roth EW, Arora K, Cueto R, Tang SC, Wilson JT, Smith AE, Werfel TA. De Mel J, et al. Among authors: wilson jt. Mol Pharm. 2022 Dec 5;19(12):4705-4716. doi: 10.1021/acs.molpharmaceut.2c00750. Epub 2022 Nov 14. Mol Pharm. 2022. PMID: 36374992 Free PMC article.
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
Wang-Bishop L, Kimmel BR, Ngwa VM, Madden MZ, Baljon JJ, Florian DC, Hanna A, Pastora LE, Sheehy TL, Kwiatkowski AJ, Wehbe M, Wen X, Becker KW, Garland KM, Schulman JA, Shae D, Edwards D, Wolf MM, Delapp R, Christov PP, Beckermann KE, Balko JM, Rathmell WK, Rathmell JC, Chen J, Wilson JT. Wang-Bishop L, et al. Among authors: wilson jt. Sci Immunol. 2023 May 12;8(83):eadd1153. doi: 10.1126/sciimmunol.add1153. Epub 2023 May 5. Sci Immunol. 2023. PMID: 37146128 Free PMC article.
410 results